Skip to main content

Powering exceptional financing solutions

We specialize in direct lending, providing a range of customized financing solutions to both private equity-sponsored and non-sponsored companies across debt and equity-related instruments. Alongside our direct lending capabilities, we employ complementary strategies through our Liquid Credit, Healthcare Opportunities, and Strategic Equity verticals.

Our difference


We are investors for the long term. Our relationship-oriented approach to investing can provide borrowers with sizable commitments to facilitate transactions and support their growth needs with certainty, speed, and transparency throughout the entire investment process. Through our extensive senior-level relationships with sponsors, we can create sourcing across multiple touchpoints. 


Led by a seasoned senior management team, our Credit platform is supported by a group of investment professionals with significant and diverse experience investing across varying market environments and business cycles.


Our dry powder allows our Credit platform to provide scaled financing solutions, commit to full capital structures, and support the future capital needs of borrowers. We focus primarily on originating and executing debt and equity investments and have demonstrated our ability to source proprietary investment opportunities with $100 billion in gross originations across our direct lending business since inception. 

Assets under management
Sponsor relationships
Investments completed

Our strategies

Across our direct lending strategies, we focus on lending to middle-market and upper-middle-market companies both non-sponsored and those backed by leading private equity sponsors, while seeking to generate current income at attractive risk-adjusted returns with a continued focus on capital preservation.

Diversified Lending

Primarily focuses on first lien, second lien, and unitranche senior secured, floating-rate loans with diversification by borrower, sector, sponsor, and position size.

First Lien Lending

Seeks to make senior secured, floating-rate investments in traditional first lien loans only and aims to have diversification by borrower, sector, sponsor, and position size.

Opportunistic Lending

Focuses on providing capital to market-leading companies and management teams that are navigating unique situations, such as transformational change, high growth, disruption, or dislocation events.

Technology Lending

Invests in a broad range of established and high-growth technology and software companies. The strategy originates and invests in debt, equity, and equity-related securities, including common equity, warrants, preferred stock, and similar forms of senior equity.

Adjacent investment strategies



Focuses on equity investments in mid- to late-stage, innovative biopharmaceutical and healthcare companies, while seeking to generate venture capital like returns with less duration. The strategy is complemented by investments in public securities that extends exposure to the public markets and captures ongoing value creation.


Focuses on the management of CLO portfolios of broadly syndicated, leveraged loans with an emphasis on liquid-market, senior secured, and floating-rate first lien loans. The strategy also invests in third-party CLO equity and junior mezzanine tranches on behalf of separately managed accounts.


Focuses on GP-led, single-asset, continuation fund investments. The strategy can provide an innovative solution for private equity sponsors, giving them a new alternative to traditional exit routes, and offers access to a diversified portfolio of some of the best trophy assets at attractive valuations.

Our investment process

  • Deal sourcing

    An independent origination process with an extensive network of industry contacts and portfolio company relationships.
  • Deal 

    Internal industry expertise informs initial evaluation of the opportunity with senior management.
  • Structuring and diligence

    Thorough review of financial information and detailed document negotiations focused on identifying and mitigating risks.
  • Investment Committee review

    Evaluate opportunity and risk-adjusted return with a focus on downside mitigation and preservation of capital.
  • Deal

    Deal terms, documentation, and timeline are finalized. Investment is allocated across managed funds as appropriate.
  • Ongoing monitoring

    Proactive review process and regular contact with portfolio company management teams and private equity sponsors.

The power of partnership

Associa Capital

Learn how Blue Owl’s direct lending helps Associa Capital to grow at an industry-leading pace featuring their President, Jose Maldonado.


Three reasons why GLG chooses direct lending as a financing solution featuring their CFO, Martijn Tel.

West Monroe

See how Blue Owl helps West Monroe build a more stable, sustainable business featuring their CFO, Zach Jones.

Certain statements about Blue Owl made by portfolio company executives herein are intended to illustrate Blue Owls' business relationship with such persons, including with respect to Blue Owls' facilities as a business partner, rather than Blue Owls' capabilities or expertise with respect to investment advisory services. Portfolio company executives were not compensated in connection with their participation, although they generally receive compensation and investment opportunities in connection with their portfolio company roles, and in certain cases are also owners of portfolio company securities and/or investors in Blue Owls - sponsored vehicles. Such compensation and investments subject participants to potential conflicts of interest in making the statements herein.

Want to see our latest results?
View our first quarter 2024 earnings.